First Affiliated Hospital Of Wenzhou Medical University
Clinical trials sponsored by First Affiliated Hospital Of Wenzhou Medical University, explained in plain language.
-
Could a common antidepressant supercharge cancer immunotherapy?
Disease control Recruiting nowThis study tests whether adding the antidepressant fluoxetine (Prozac) to standard immunotherapy can help control tumors better in people with advanced liver or gallbladder cancer who also have depression or anxiety. About 240 participants will be randomly assigned to receive imm…
Phase: PHASE2 • Sponsor: First Affiliated Hospital of Wenzhou Medical University • Aim: Disease control
Last updated May 26, 2026 05:06 UTC
-
New Alzheimer's drug lecanemab put to the test in major Multi-Omics study
Disease control Recruiting nowThis study is testing the drug lecanemab in 200 people with early-to-moderate Alzheimer's disease. Participants will receive either lecanemab or standard treatment for 24 months. Researchers will use brain scans, eye imaging, and memory tests to see if the drug slows the disease …
Phase: PHASE4 • Sponsor: First Affiliated Hospital of Wenzhou Medical University • Aim: Disease control
Last updated May 26, 2026 05:04 UTC
-
New combo therapy aims to shrink rectal tumors before surgery
Disease control Recruiting nowThis study tests a new treatment plan for people with a certain type of locally advanced rectal cancer (MSS-type). The plan combines short-course radiation, chemotherapy, an immunotherapy drug (serplulimab), and a targeted therapy (bevacizumab) before surgery. The goal is to see …
Phase: PHASE2 • Sponsor: First Affiliated Hospital of Wenzhou Medical University • Aim: Disease control
Last updated May 26, 2026 04:36 UTC
-
New drug hope for lung scarring: anlotinib trial begins
Disease control Recruiting nowThis study tests whether anlotinib capsules can improve lung function in people with idiopathic pulmonary fibrosis (IPF) or progressive fibrosis-interstitial lung diseases (PF-ILDs). About 30 adults aged 40-85 will receive either anlotinib or a placebo. The main goal is to see if…
Phase: PHASE2, PHASE3 • Sponsor: First Affiliated Hospital of Wenzhou Medical University • Aim: Disease control
Last updated May 08, 2026 12:02 UTC
-
Could a stroke drug boost brain power in seniors with epilepsy?
Symptom relief Recruiting nowThis study tests whether butylphthalide, a drug already used for stroke, can improve memory and thinking in older adults (ages 60-85) who have focal epilepsy and mild to moderate cognitive problems. About 220 participants will take either the drug or a placebo for 48 weeks while …
Phase: PHASE4 • Sponsor: First Affiliated Hospital of Wenzhou Medical University • Aim: Symptom relief
Last updated May 26, 2026 05:04 UTC